TRIM29, also known as Ataxia-telangiectasia group D, was identified for its capacity to induce resistance to ionizing radiation (IR) in cells derived from patients with ataxia telangiectasia, a disorder characterized by ATM (Ataxia Telangiectasia-Mutated) deficiency. Here, ATM is linked to Ataxia-telangiectasia.